These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9284796)

  • 1. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy.
    Stein DS
    Lancet; 1997 Aug; 350(9077):589-90. PubMed ID: 9284796
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy.
    Mitchell SM; Youle MS; Membrey WL; Jones CD
    Lancet; 1997 Aug; 350(9077):588; author reply 590. PubMed ID: 9284792
    [No Abstract]   [Full Text] [Related]  

  • 3. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy.
    Carr A; Cooper DA
    Lancet; 1997 Aug; 350(9077):589; author reply 590. PubMed ID: 9284795
    [No Abstract]   [Full Text] [Related]  

  • 4. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy.
    Stricker RB; Goldberg B
    Lancet; 1997 Aug; 350(9077):589; author reply 590. PubMed ID: 9284794
    [No Abstract]   [Full Text] [Related]  

  • 5. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy.
    Uthayakumar S; Birthistle K; Dalton R; Hay PE
    Lancet; 1997 Aug; 350(9077):588-9; author reply 590. PubMed ID: 9284793
    [No Abstract]   [Full Text] [Related]  

  • 6. Relapse of CMV retinitis in an AIDS patient with high CD4 counts.
    Petit N; Zandotti C; Riss JM; Frippiat F; Moulin JF; Gastaut JA
    J Antimicrob Chemother; 1998 Jun; 41(6):666-7. PubMed ID: 9687110
    [No Abstract]   [Full Text] [Related]  

  • 7. Loss of cytomegalovirus-specific CD4+ T cell responses in human immunodeficiency virus type 1-infected patients with high CD4+ T cell counts and recurrent retinitis.
    Komanduri KV; Feinberg J; Hutchins RK; Frame RD; Schmidt DK; Viswanathan MN; Lalezari JP; McCune JM
    J Infect Dis; 2001 Apr; 183(8):1285-9. PubMed ID: 11262214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune recovery vitritis in HIV infection: abstracts and commentary.
    Dunn JP
    JAMA; 1998 Jul; 280(2):185-6. PubMed ID: 9669796
    [No Abstract]   [Full Text] [Related]  

  • 9. Characterization of reactivation of cytomegalovirus retinitis in patients healed after treatment with highly active antiretroviral therapy.
    Song MK; Karavellas MP; MacDonald JC; Plummer DJ; Freeman WR
    Retina; 2000; 20(2):151-5. PubMed ID: 10783947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy.
    Jacobson MA; Zegans M; Pavan PR; O'Donnell JJ; Sattler F; Rao N; Owens S; Pollard R
    Lancet; 1997 May; 349(9063):1443-5. PubMed ID: 9164318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrences of cytomegalovirus retinitis in a human immunodeficiency virus-infected patient, despite potent antiretroviral therapy and apparent immune reconstitution.
    Johnson SC; Benson CA; Johnson DW; Weinberg A
    Clin Infect Dis; 2001 Mar; 32(5):815-9. PubMed ID: 11229851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the benefits and limits of highly active antiretroviral therapy.
    D'Aquila R; Walker B
    JAMA; 1999 Nov; 282(17):1668-9. PubMed ID: 10553795
    [No Abstract]   [Full Text] [Related]  

  • 13. Anti-HIV drugs allow immune system to rebound, fight CMV.
    Optom Vis Sci; 2000 Jan; 77(1):3. PubMed ID: 10654853
    [No Abstract]   [Full Text] [Related]  

  • 14. Changing trends in cytomegalovirus retinitis with highly active anti-retroviral therapy (HAART).
    Dhillon B; Ramaesh K; Leen C
    Eye (Lond); 1999 Jun; 13 ( Pt 3a)():275-6. PubMed ID: 10624419
    [No Abstract]   [Full Text] [Related]  

  • 15. Association of cytomegalovirus (CMV)-specific CD4+ T lymphocyte reactivity and protective immunity against acquired immunodeficiency syndrome-related CMV retinitis.
    Jacobson MA; Bredt BM
    J Infect Dis; 2002 Dec; 186(11):1701-2; author reply 1702-3. PubMed ID: 12447752
    [No Abstract]   [Full Text] [Related]  

  • 16. Control of cytomegalovirus retinitis after combination antiretroviral therapy.
    Ruhswurm I; Ries E; Krepler K; Derbolav A; Rieger A; Armbruster C; Wedrich A
    Acta Ophthalmol Scand; 1999 Aug; 77(4):471-3. PubMed ID: 10463426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of untreated AIDS-related cytomegalovirus retinitis. II. Findings in the era of highly active antiretroviral therapy (1997 to 2000).
    Holland GN; Vaudaux JD; Shiramizu KM; Yu F; Goldenberg DT; Gupta A; Carlson M; Read RW; Novack RD; Kuppermann BD;
    Am J Ophthalmol; 2008 Jan; 145(1):12-22. PubMed ID: 18154751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytomegalovirus retinitis and low CD4+ T-lymphocyte counts.
    Baldassano V; Dunn JP; Feinberg J; Jabs DA
    N Engl J Med; 1995 Sep; 333(10):670. PubMed ID: 7637742
    [No Abstract]   [Full Text] [Related]  

  • 19. Editorial comment: failure of HAART to reconstitute CMV-specific protective immunity.
    Jacobson MA
    AIDS Read; 2005 Apr; 15(4):188. PubMed ID: 15844239
    [No Abstract]   [Full Text] [Related]  

  • 20. Natural history and outcome of new AIDS-related cytomegalovirus retinitis diagnosed in the era of highly active antiretroviral therapy.
    Jacobson MA; Stanley H; Holtzer C; Margolis TP; Cunningham ET
    Clin Infect Dis; 2000 Jan; 30(1):231-3. PubMed ID: 10619774
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.